Back

Stereo-Encephalography-Guided Multi Lead Deep Brain Stimulation for Treatment-Refractory Obsessive Compulsive Disorder - Study Design and Individualized Surgical Targeting Approach

Seilheimer, R. L.; Qiu, L.; Rocchio, G.; Nho, Y.-H.; Campos, G.; Pesaran, B.; Williams, N. R.; Rolle, C. E.; Buch, V. P.; Ganguly, T. M.; Miller, K. J.; Cristancho, M.; Oathes, D. J.; Brown, L.; Scangos, K. W.; Barbosa, D. A. N.; Halpern, C. H.

2025-04-21 surgery
10.1101/2025.04.17.25325961
Show abstract

IntroductionTreatment-refractory obsessive-compulsive disorder (trOCD) is a complex network disorder that may require personalized treatment strategies due to disease heterogeneity. A multi-site, multi-stage, double-blinded, randomized crossover clinical trial is underway, using stereo electroencephalography (sEEG) to guide selection of multi-nodal targets for deep brain stimulation (DBS) for trOCD. ObjectivesTo describe the clinical trial design, emphasizing personalized surgical targeting strategies that ensure the feasibility and precision of sEEG electrode placement, and enable adequate sampling of relevant targets in trOCD for network evaluation and modulation. MethodsAdults with severe trOCD (Yale-Brown Obsessive Compulsive Scale [≥] 28) who meet eligibility criteria are enrolled in this three-stage clinical trial (NCT05623306). Stage 1 involves SEEG electrode implantation in trOCD implicated regions and inpatient evaluation. Individualized probabilistic-tractography-guided target refinement is performed for surgical planning. Multimodal recordings are taken while participants stay in the psychiatric monitoring unit for 12 days. In stage 2, up to four permanent DBS electrodes are implanted followed by stimulation optimization. Stage 3 is the randomized, double blinded cross over phase. Expected OutcomesSafety, feasibility and preliminary efficacy will be assessed in this ongoing study. We anticipate that the use of sEEG to guide selection of multi-nodal targets for DBS will be safe, feasible and result in clinically meaningful improvements in symptom severity and functional impairment in trOCD. DiscussionWe present the clinical protocol of sEEG-guided investigation of brain networks involved in trOCD and describe our tractography-guided surgical targeting strategy designed to optimize individualized network engagement and neuromodulation.

Matching journals

1
Brain Communications
Oxford University Press (OUP) · based on 79 published papers
#1
67× avg
2
Human Brain Mapping
Wiley · based on 53 published papers
Top 0.2%
52× avg
3
Neurobiology of Disease
Elsevier BV · based on 12 published papers
#1
204× avg
4
Brain
Oxford University Press (OUP) · based on 69 published papers
Top 2%
14× avg
5
Journal of Affective Disorders
Elsevier BV · based on 72 published papers
Top 2%
12× avg
6
Journal of Psychiatric Research
Elsevier BV · based on 22 published papers
Top 0.2%
60× avg
7
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 75%
3.2%
8
Brain Stimulation
Elsevier BV · based on 27 published papers
Top 1%
20× avg
9
Frontiers in Psychiatry
Frontiers Media SA · based on 56 published papers
Top 4%
7.4× avg
10
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 67%
1.9%
11
British Journal of Anaesthesia
Elsevier BV · based on 13 published papers
Top 1%
12× avg
12
Translational Psychiatry
Springer Science and Business Media LLC · based on 94 published papers
Top 6%
3.3× avg
13
Journal of Neurology, Neurosurgery & Psychiatry
BMJ · based on 26 published papers
Top 3%
8.4× avg
14
eLife
eLife Sciences Publications, Ltd · based on 262 published papers
Top 23%
1.3%
15
npj Digital Medicine
Springer Science and Business Media LLC · based on 85 published papers
Top 11%
1.7× avg
16
NeuroImage: Clinical
Elsevier BV · based on 77 published papers
Top 6%
3.3× avg
17
PLOS Computational Biology
Public Library of Science (PLoS) · based on 141 published papers
Top 9%
1.6× avg
18
Biology Methods and Protocols
Oxford University Press (OUP) · based on 19 published papers
Top 2%
7.5× avg
19
BMC Neurology
Springer Science and Business Media LLC · based on 11 published papers
Top 3%
8.8× avg
20
Neuropsychopharmacology
Springer Science and Business Media LLC · based on 29 published papers
Top 3%
6.1× avg
21
Psychiatry Research
Elsevier BV · based on 33 published papers
Top 5%
3.8× avg